Brief: Silexion Therapeutics Says Nasdaq Confirms Co's Compliance For Continued Listing
25/09/2025 13:40
Sept 25 (Reuters) - Silexion Therapeutics Corp SLXN.O: SILEXION THERAPEUTICS CORP - NASDAQ CONFIRMS CO'S COMPLIANCE FOR CONTINUED LISTING - SEC FILING Source text: [ID:n0001178913-25-003374] Further company coverage: SLXN.O ((Reuters.Briefs@thomsonreuters.com;))